Thanatophoric Dysplasia
DOI:
https://doi.org/10.25077/aoj.5.1.112-118.2021Abstract
Background: The term tanatophorik comes from the Greek word thanatophorus which means "innate death" or "bearing death". The problem that underlies this disease is the process of bone formation. This disease is associated with an autosomal dominant inherited mutation of the fibroblast growth factor 3 receptor (FGFR3) gene on the arm of chromosome 4 (4p16.3). Because FGFR3 is the main modulator in bone formation, the typical clinical features of this disease include shortening of the extremities, curved femur, clover-like skull and narrowing of the thoracic cavity.Tanatophoric dysplasia is a skeletal disorder that is "lethal" or deadly. The deaths occurred due to respiratory failure caused by reduced chest cavity capacity, hypoplastic lungs and / or brainstem compression.
Destination: Reported a case of thanatophoric dysplasia
Method: Case Report
Case Report: Case 33 years old woman, with preterm parturient G1P0A0H0 35-36 weeks 1 latent phase + history of 2x laparotomy + suspected fetal tanatophoric dysplasia. On ultrasound examination, it was found that BPD = 9.14 cm; AC = 30.56 cm; HC = 32.05 cm; FL = 2.55 cm; AFI; 9.06cm; SDAU = 1.72 cm. The presence of frontal bosing, saddle nose and micromilia (proximal, distal, phalanges) was found. The patient was planned for vaginal delivery and the progress of labor was followed. Patients provided informed consent regarding the possibility of fetal death during labor and after birth. During the active phase of the labor process, hypotony uterine innersia occurs and oxytocin drip is performed to accelerate labor. The baby was born male, weight 2175 grams, body length 34 cm and A / S: 1/0. Postmortem physical examination revealed macroscopic findings of tanatophoric dysplasia infants such as hypertelorism, low nasal bridge, cranio-facial disproportion. Narrow chest with protruding abdomen and short, bent limbs.
Conclusion: Tanatophoric dysplasia is "lethal" skeletal dysplasia. Careful prenatal examination is required in diagnosis and termination of pregnancy.
Keywords: Thanatophoric dysplasia, prenatal diagnosisReferences
Dighe M, Fligner C, Cheng E, et al. 2008. Fetal Skeletal Dysplasia: An Approach to Diagnosis with Illustrative Case. RadioGraphics. 28 (4): 1061-76.
Naveen NS, Murlimanju BV, Kumar V, Pulakunta T. 2011. Thanatophoric dysplasia: a rare entity. Oman Med J. 26 (3): 196-7.
Jung M, Park SH. 2017. Genetically confirmed thanatophoric dysplasia with fibroblast growth factor receptor 3 mutations. Exp Mol Pathol. 102 (2): 290-5.
Chen SW, Chen CP, Wang, LK, et al. 2017. Perinatal imaging findings and molecular genetic analysis of thanatophoric dysplasia type 1 in a fetus with a c.2419T> G (p.Ter807Gly) (X807G) mutation in FGFR3. Taiwanese Journal of Obstetrics and Gynecology. 56: 87-92.
Nikkel SM, Major N, King WJ. 2013. Growth and development in thanatophoric dysplasia - an update 25 years later. Clin Case Rep. 1 (2): 75-8.
Chen CP, Chang TY, Lin TW, et al. 2018. Prenatal Diagnosis of Hydrancephaly and Enlarged Cerebellum and Cisterna magna in a Fetus with Thanatophoric Dysplasia Type II and A Review of Prenatal Diagnosis of Brain Anomalies Associated with Thanatophoric Dysplasia. Taiwanese Journal of Obstetrics and Gynecology. 57: 119-22.
Miler E, Blaser S, Shannon P, Widjaja E. 2009. Brain and Bone Abnormalities of Thanatophoric Dwarfism. Neuroradiology / Head and Neck Imaging. AJR: 192.
Wang L, Takai Y, Baba K, et al. 2017. Can biparietal diameter-to-femur length ratio be a useful sonographic marker for screening than atophoric dysplasia since the first trimester? A literature review of case reports and a retrospective study based on 10,293 routine fetal biometry measurements. Taiwan J Obstet Gynecol. 56 (3): 374-8.
Oliveira CIF, Fett-Conte AC. Birth defects: Risk factors and consequences. Journal of Pediatric Genetics. 2013; 2 (2): 85-90.
López †Camelo JS, Castilla EE, Orioli IM. Folic acid flour fortification: impact on the frequencies of 52 congenital anomaly types in three South American countries. American Journal of Medical Genetics Part A.2010; 152 (10): 2444-58.
Shum L, Nuckolls G. The life cycle of chondrocytes in the developing skeleton. Arthritis Research & Therapy. 2001; 4 (2): 1
Jeanty P, Valero G. The assessment of the fetus with a skeletal dysplasia.
Teven CM, Farina EM, Rivas J, Reid RR. Fibroblast growth factor (FGF) is signaling in development and skeletal diseases. Genes & Diseases. 2014; 1 (2): 199-213.
Dighe M, Fligner C, Cheng E, Warren B, Dubinsky T. Fetal Skeletal Dysplasia: An Approach to Diagnosis with Illustrative Cases 1. Radiographics. 2008; 28 (4): 1061-77.
Karczeski B, Cutting GR. Thanatophoric dysplasia. 2013.
Chitty LS, Khalil A, Barrett AN, Pajkrt E, Griffin DR, Cole TJ. Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA. Prenatal diagnosis. 2013; 33 (5): 416-23.
Krakow D, Lachman RS, Rimoin DL. Guidelines for the prenatal diagnosis of fetal skeletal dysplasias. Genetics IN Medicine. 2009; 11 (2): 127-33.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Andalas Obstetrics And Gynecology Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
Authors who publish with this journal agree to the following terms:
- Authors retain the copyright of published articles and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
License:
Andalas Obstetrics and Gynecology Journal (AOJ) is published under the terms of the Creative Commons Attribution 4.0 International License. This license permits anyone to copy and redistribute this material in any form or format, compose, modify, and make derivatives of this material for any purpose, including commercial purposes, as long as they credit the author for the original work.